等待開盤 03-27 09:30:00 美东时间
-0.045
-3.26%
今日重点评级关注:LUCID CAPITAL MARKETS:上调INmune Bio评级至"买入" 目标价从2美元升至9美元;Clear Street:维持MoonLake Immunotherapeutics Class A"买入"评级,目标价从45美元升至70美元
03-12 12:34
RBC Capital analyst Ben Hendrix maintains eHealth (NASDAQ:EHTH) with a Sector Perform and lowers the price target from $9 to $3.
03-11 22:22
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
Craig-Hallum analyst George Sutton downgrades eHealth (NASDAQ:EHTH) from Buy to Hold and announces $2 price target.
02-27 01:59
eHealth shares are trading lower after the company reported Q4 financial result...
02-27 00:50
Companies Reporting Before The Bell • Clear Secure (NYSE:YOU) is expected to re...
02-25 19:11
Albert to Sharpen Focus on Improving Cost and Operational Efficiency,Clinical Quality, and Consumer Experience in HealthcareHealth Catalyst Board to be Reduced to Five DirectorsImmediately Prior to the 2026 Annual
02-18 21:59
Nyxoah has signed a Memorandum of Understanding with Sheikh Shakhbout Medical City (SSMC) to enhance OSA therapy management and accelerate Genio access in the Middle East. The collaboration aims to establish SSMC as a regional center for Genio therapy, supporting high-volume implant programs and patient-centered care. SSMC will also serve as a training hub for Genio therapy, educating surgeons and healthcare professionals. Nyxoah and SSMC are exp...
02-18 21:05
eHealth Inc. to Hold Earnings Call on Upcoming Financial Results eHealth Inc. will release its fourth quarter and fiscal year 2025 financial results on February 25, 2026. The company will hold an earnings conference call on the same day at 5:00 p.m. Eastern Time, hosted by CEO Derrick Duke and CFO J
02-10 06:50
eHealth Inc. kündigt Finanz-Update an eHealth Inc. wird am 25. Februar 2026 die Ergebnisse für das vierte Quartal und das Geschäftsjahr 2025 veröffentlichen. Eine Telefonkonferenz zur Präsentation der Ergebnisse beginnt um 17:00 Uhr Eastern Time, moderiert von CEO Derrick Duke und CFO John Dolan. Di
02-10 06:50